Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Value Stock, Under Radar
841.2500 -4.85 (-0.57%)
NSE Sep 09, 2025 15:31 PM
Volume: 200.8K
 

logo
Natco Pharma Ltd.
28 May 2019
841.25
-0.57%
ICICI Securities Limited
Natco has carved out its own identity via tie-ups to tap limited but niche products pipeline including 16 Para IVs and two limited competition products (FY18). As per the revised and more feasible game plan, it plans to market products via tie-ups with established players in the generic space. Till FY18, the company filed 45 ANDAs, which includes some niche FTF...
Number of MF schemes decreased from 54 to 47 in Jun 2025 qtr
More from Natco Pharma Ltd.
Recommended